{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:40:39Z","timestamp":1790984439731,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.jconrel.2006.11.002","type":"journal-article","created":{"date-parts":[[2006,11,14]],"date-time":"2006-11-14T15:46:46Z","timestamp":1163519206000},"page":"171-178","source":"Crossref","is-referenced-by-count":54,"title":["N-sulfonato-N,O-carboxymethylchitosan: A novel polymeric absorption enhancer for the oral delivery of macromolecules"],"prefix":"10.1016","volume":"117","author":[{"given":"M.","family":"Thanou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kydonieus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Elson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2006.11.002_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1567201052772834","article-title":"Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery","volume":"2","author":"Cano-Cebrian","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2006.11.002_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/02648725.2000.10648001","article-title":"Modulation of intestinal permeability: a novel and innovative approach for the oral delivery of drugs, macromolecules and antigens","volume":"17","author":"Watts","year":"2000","journal-title":"Biotechnol. Genet. Eng. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2006.11.002_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","article-title":"Challenges for the oral delivery of macromolecules","volume":"2","author":"Goldberg","year":"2003","journal-title":"Nat. Rev., Drug Discov."},{"issue":"3","key":"10.1016\/j.jconrel.2006.11.002_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0169-409X(00)00045-4","article-title":"The molecular structure of the tight junction","volume":"41","author":"Lapierre","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2006.11.002_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1567201054367968","article-title":"Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers","volume":"2","author":"Ross","year":"2005","journal-title":"Curr. Drug Deliv."},{"issue":"17 Suppl","key":"10.1016\/j.jconrel.2006.11.002_bib6","first-page":"S535","article-title":"Economic issues in the treatment and prevention of deep vein thrombosis from a managed care perspective","volume":"7","author":"de Lissovoy","year":"2001","journal-title":"Am. J. Manag. Care"},{"issue":"8","key":"10.1016\/j.jconrel.2006.11.002_bib7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2165\/00003495-200161080-00017","article-title":"Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism","volume":"61","author":"Wellington","year":"2001","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jconrel.2006.11.002_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.beha.2004.03.007","article-title":"Oral delivery of heparin: SNAC and related formulations","volume":"17","author":"Pineo","year":"2004","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"9","key":"10.1016\/j.jconrel.2006.11.002_bib9","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1046\/j.1538-7836.2003.00340.x","article-title":"Oral heparin administration with a novel drug delivery agent (SNAC) in healthy volunteers and patients undergoing elective total hip arthroplasty","volume":"1","author":"Berkowitz","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.jconrel.2006.11.002_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00063198-200109000-00016","article-title":"Orally active heparin and low-molecular-weight heparin","volume":"7","author":"Pineo","year":"2001","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2006.11.002_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00000658-200006000-00002","article-title":"Treatment of experimentally induced caval thrombosis with oral low molecular weight heparin and delivery agent in a porcine model of deep venous thrombosis","volume":"231","author":"Salartash","year":"2000","journal-title":"Ann. Surg."},{"issue":"8","key":"10.1016\/j.jconrel.2006.11.002_bib12","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1023\/A:1019802310702","article-title":"Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino] caprylate","volume":"19","author":"Malkov","year":"2002","journal-title":"Pharm. Res."},{"issue":"25","key":"10.1016\/j.jconrel.2006.11.002_bib13","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1161\/hc5001.100627","article-title":"Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent","volume":"104","author":"Lee","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jconrel.2006.11.002_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.thromres.2005.03.027","article-title":"Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation","volume":"117","author":"Kim","year":"2006","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2006.11.002_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2005.12.011","article-title":"Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys","volume":"111","author":"Lee","year":"2006","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.jconrel.2006.11.002_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/10611860500471906","article-title":"Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels","volume":"13","author":"Motlekar","year":"2005","journal-title":"J. Drug Target."},{"issue":"4","key":"10.1016\/j.jconrel.2006.11.002_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","article-title":"Intestinal permeation enhancers","volume":"89","author":"Aungst","year":"2000","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2006.11.002_bib18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1023\/A:1023803706746","article-title":"Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil","volume":"20","author":"Kast","year":"2003","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2006.11.002_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0169-409X(01)00231-9","article-title":"Oral drug absorption enhancement by chitosan and its derivatives","volume":"52","author":"Thanou","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2006.11.002_bib20","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1023\/A:1013055120007","article-title":"Enhancement of the intestinal absorption of low molecular weight heparin (LMWH) in rats and pigs using Carbopol 934P","volume":"18","author":"Thanou","year":"2001","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2006.11.002_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2003.05.001","article-title":"Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer\/GSH systems","volume":"93","author":"Bernkop-Schnurch","year":"2003","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2006.11.002_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1517\/17425247.1.1.87","article-title":"Thiomers for oral delivery of hydrophilic macromolecular drugs","volume":"1","author":"Bernkop-Schnurch","year":"2004","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.jconrel.2006.11.002_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1520-6017(200101)90:1<38::AID-JPS5>3.0.CO;2-3","article-title":"Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo","volume":"90","author":"Thanou","year":"2001","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2006.11.002_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/107602960100700303","article-title":"Anticoagulation: the present and future","volume":"7","author":"Van Aken","year":"2001","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.jconrel.2006.11.002_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1007558206506","article-title":"N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats)","volume":"17","author":"Thanou","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2006.11.002_bib26","unstructured":"E. Hayes, N,O-carboxymethyl chitosan and preparative method therefor US4619995 (1986)."},{"key":"10.1016\/j.jconrel.2006.11.002_bib27","unstructured":"Q.P. Peniston, E.L. Johnson, Process for depolymerization of chitosan. US3922260 (1975)."},{"issue":"1\u20133","key":"10.1016\/j.jconrel.2006.11.002_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"Artursson","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.jconrel.2006.11.002_bib29","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood.V99.6.1965","article-title":"Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis","volume":"99","author":"Kakkar","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jconrel.2006.11.002_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1517\/14656566.3.2.173","article-title":"Reviparin sodium \u2014 a new low molecular weight heparin","volume":"3","author":"Breddin","year":"2002","journal-title":"Expert Opin. Pharmacother."},{"issue":"1","key":"10.1016\/j.jconrel.2006.11.002_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-0037-1612913","article-title":"Antithrombotic efficacy in a rat model of the low molecular weight heparin, reviparin sodium, administered by the oral route","volume":"85","author":"Hiebert","year":"2001","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.jconrel.2006.11.002_bib32","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1023\/A:1018967116988","article-title":"Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)","volume":"11","author":"Artursson","year":"1994","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2006.11.002_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/1568026013395010","article-title":"Assessing the absorption of new pharmaceuticals","volume":"1","author":"Hidalgo","year":"2001","journal-title":"Curr. Top Med. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2006.11.002_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/10611860400020191","article-title":"Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin","volume":"13","author":"Yang","year":"2005","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.jconrel.2006.11.002_bib35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/hc0202.101988","article-title":"In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits","volume":"105","author":"Jiao","year":"2002","journal-title":"Circulation"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365906006122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365906006122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T10:03:21Z","timestamp":1555927401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365906006122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0168365906006122"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2006.11.002","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}